Trial intelligence / Profile preview

Diractin (ketoprofen in Transfersome gel) for osteoarthritis of the knee

2006-006298-26Phase 3Completed

Sponsor
IDEA AG
Start
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of diractin in knee osteoarthritis (OA) and osteoarthritis (OA) (4 arms), sponsored by IDEA AG. Primary endpoint: Primary efficacy endpoint. Started Jan 2008; status: completed.

02

Drugs

diractin
03

Conditions

knee osteoarthritis (OA)osteoarthritis (OA)

Beyond the preview

Go deeper on 2006-006298-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006298-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call